Critical incident monitoring has the advantage of identifying a potential risk to the patient without it necessarily resulting in morbidity. An added advantage in developing countries is the low cost involved in introducing the programme. This paper analyses the incidents reported from the operating
Intravenous buscopan for analgesia following laparoscopic sterilisation
โ Scribed by C. M. Wilson; N. Lillywhite; B. Matta; P. Mills; S. Wiltshire
- Book ID
- 104456019
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 366 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0003-2409
No coin nor oath required. For personal study only.
โฆ Synopsis
Following reports that tubal smooth muscle spasm may contribute to pelvic pain following laparoscopic sterilisation, we studied the effect of buscopan (an anticholinergic agent used to relieve smooth muscle spasm) on 45 patients undergoing general anaesthesia for day-case laparoscopic sterilisation. Patients were randomly allocated to receive either buscopan 20 mg or saline placebo after induction of anaesthesia. There were no significant differences in pain scores or postoperative analgesic requirements between the two groups. We conclude that intravenous buscopan confers no benefit in day-case laparoscopic sterilisation.
๐ SIMILAR VOLUMES